scholarly journals 153 The Effect of Nerve Growth Factor Beta on Embryonic Cleavage Rates

2020 ◽  
Vol 98 (Supplement_2) ◽  
pp. 82-83
Author(s):  
Kayla Jones
Keyword(s):  
Nerve Growth Factor ◽  
Growth Factor ◽  
In Vitro Fertilization ◽  
Culture Media ◽  
In Vivo Studies ◽  
Nerve Growth ◽  
Vitro Fertilization ◽  
Embryonic Cleavage ◽  
Conception Rates

Abstract Nerve growth factor (NGF) beta is a seminal plasma protein that has been associated with sire conception rates in cattle. Previous research showed that the administration of NGFβ, via culture media, to cows resulted in improved conceptus development. Though this finding was thought to be an indirect effect of improved corpus luteum (CL) function, questions raised if NGFβ could act directly on the embryo to promote development. This work seeks to determine the effect of NGFβ supplementation during in-vitro fertilization (IVF) on cleavage and blastocyst rates. How does the administration of NGFβ in culture media affect cleavage and blastocyst rates during in-vitro fertilization? Abattoir-derived bovine ovaries were used for recovery of cumulus-oocyte complexes (COC). Selected COC were placed in the maturation medium. Expanded COC were inseminated with frozen-thawed spermatozoa, and IVF media was supplemented with either 0 ng/mL or 100 ng/mL NGF. Presumptive zygotes were transferred to development medium in a tri-gas chamber with 5% CO2, 5% O2, and 90% N2 in a humidified atmosphere at 39°C, mimicking the bovine uterine climate, until 8 days. Treatment with NGFβ increased the percentage of cleaved embryos at 48 hours and the percentage of hatched embryos at 8 days per oocyte. Treatment of NGFβ did not alter the percentage of blastocysts per cleaved embryo or the percentage of hatched blastocysts. These results show that the NGFβ can act directly on the embryo during fertilization to alter embryonic development, specifically embryonic cleavage rates. Future in vivo studies should assess the downstream effects of NGF treatment on conception rates in cattle.

scholarly journals 152 The Effect of Nerve Growth Factor Beta on Embryonic Cleavage Rates

2020 ◽  
Vol 98 (Supplement_2) ◽  
pp. 51-51
Author(s):  
Kayla Jones
Keyword(s):  
Nerve Growth Factor ◽  
Growth Factor ◽  
In Vitro Fertilization ◽  
Culture Media ◽  
In Vivo Studies ◽  
Nerve Growth ◽  
Vitro Fertilization ◽  
Embryonic Cleavage ◽  
Conception Rates

Abstract Nerve growth factor, (NGF) beta is a seminal plasma protein that has been associated with sire conception rates in cattle. Previous research showed that the administration of NGFβ, via culture media, to cows resulted in improved conceptus development. Though this finding was thought to be an indirect effect of improved corpus luteum (CL) function, questions raised if NGFβ could act directly on the embryo to promote development. This work seeks to determine the effect of NGFβ supplementation during in-vitro fertilization (IVF) on cleavage and blastocyst rates. How does the administration of NGFβ in culture media affect cleavage and blastocyst rates during in-vitro fertilization? Abattoir-derived bovine ovaries were used for recovery of cumulus-oocyte complexes (COC). Selected COC were placed in the maturation medium. Expanded COC were inseminated with frozen-thawed spermatozoa, and IVF media was supplemented with either 0 ng/mL or 100 ng/mL NGF. Presumptive zygotes were transferred to development medium in a tri-gas chamber with 5% CO2, 5% O2, and 90% N2 in a humidified atmosphere at 39°C, mimicking the bovine uterine climate, until 8 days. Treatment with NGFβ increased the percentage of cleaved embryos at 48 hours and the percentage of hatched embryos at 8 days per oocyte. Treatment of NGFβ did not alter the percentage of blastocysts per cleaved embryo or the percentage of hatched blastocysts. These results show that the NGFβ can act directly on the embryo during fertilization to alter embryonic development, specifically embryonic cleavage rates. Future in vivo studies should assess the downstream effects of NGF treatment on conception rates in cattle.

Regulation of nerve growth factor receptor mRNA content by dexamethasone: In vitro and in vivo studies

1990 ◽  
Vol 116 (1-2) ◽  
pp. 216-220 ◽  
Author(s):  
Alexander G. Yakovlev ◽  
Maria A. De Bernardi ◽  
Michele Fabrazzo ◽  
Gary Brooker ◽  
Erminio Costa ◽  
...  
Keyword(s):  
Nerve Growth Factor ◽  
Growth Factor ◽  
Growth Factor Receptor ◽  
Nerve Growth Factor Receptor ◽  
In Vivo Studies ◽  
Nerve Growth ◽  
Receptor Mrna ◽  
Mrna Content

Neuroprotective and anti-amnestic effects of a combination therapy in a model of photochemical ischemic damage in the prefrontal cortex

2018 ◽  
pp. 39-45
Author(s):  
Ф.М. Шакова ◽  
Т.И. Калинина ◽  
М.В. Гуляев ◽  
Г.А. Романова
Keyword(s):  
Prefrontal Cortex ◽  
Nerve Growth Factor ◽  
Growth Factor ◽  
Combination Therapy ◽  
Neuroprotective Effect ◽  
Regulatory Protein ◽  
Human Growth ◽  
Neuroprotective Effects ◽  
Nerve Growth

Цель исследования - изучение влияния комбинированной терапии (мутантные молекулы эритропоэтина (EPO) и дипептидный миметик фактора роста нервов ГК-2H) на воспроизведение условного рефлекса пассивного избегания (УРПИ) и объем поражения коры мозга у крыс с двусторонним ишемическим повреждением префронтальной коры. Методика. Мутантные молекулы EPO (MЕРО-TR и MЕPО-Fc) с значительно редуцированной эритропоэтической и выраженной цитопротекторной активностью созданы методом генной инженерии. Используемый миметик фактора роста нервов человека, эндогенного регуляторного белка, в экспериментах in vitro проявлял отчетливые нейропротективные свойства. Двустороннюю фокальную ишемию префронтальной коры головного мозга крыс создавали методом фотохимического тромбоза. Выработку и оценку УРПИ проводили по стандартной методике. Объем повреждения мозга оценивался при помощи МРТ. MEPO-TR и MEPO-Fc (50 мкг/кг) вводили интраназально однократно через 1 ч после фототромбоза, ГК-2Н (1 мг/кг) - внутрибрюшинно через 4 ч после фототромбоза и далее в течение 4 послеоперационных суток. Результаты. Выявлено статистически значимое сохранение выработанного до ишемии УРПИ, а также значимое снижение объема повреждения коры при комплексной терапии. Полученные данные свидетельствуют об антиамнестическом и нейропротекторном эффектах примененной комбинированной терапии, которые наиболее отчетливо выражены в дозах: МEPO-Fc (50 мкг/кг) и ГК-2Н (1 мг/кг). Заключение. Подтвержден нейропротекторный эффект и усиление антиамнестического эффекта при сочетанном применении мутантных производных эритропоэтина - MEPO-TR и MEPO-Fc и дипептидного миметика фактора роста нервов человека ГК-2H. The aim of this study was to investigate the effect of combination therapy, including mutant erythropoietin molecules (EPO) and a dipeptide mimetic of the nerve growth factor, GK-2H, on the conditioned passive avoidance (PA) reflex and the volume of injury induced by bilateral ischemia of the prefrontal cortex in rats. Using the method of genetic engineering the mutant molecules of EPO, MERO-TR and MEPO-Fc, with strongly reduced erythropoietic and pronounced cytoprotective activity were created. The used human nerve growth factor mimetic, an endogenous regulatory protein based on the b-bend of loop 4, which is a dimeric substituted dipeptide of bis- (N-monosuccinyl-glycyl-lysine) hexamethylenediamine, GK-2 human (GK-2H), has proven neuroprotective in in vitro experiments. Methods. Bilateral focal ischemic infarction was modeled in the rat prefrontal cortex by photochemically induced thrombosis. The PA test was performed according to a standard method. Volume of brain injury was estimated using MRI. MEPO-TR, and MEPO-Fc (50 mg/kg, intranasally) were administered once, one hour after the injury. GK-2Н (1 mg/kg, i.p.) was injected four hours after the injury and then for next four days. Results. The study showed that the complex therapy provided statistically significant retention of the PA reflex developed prior to ischemia and a significant decrease in the volume of injury. The anti-amnestic and neuroprotective effects of combination therapy were most pronounced at doses of MEPO-Fc 50 mg/kg and GK-2H 1 mg/kg. Conclusion. This study has confirmed the neuroprotective effect and enhancement of the anti-amnestic effect exerted by the combination of mutant erythropoietin derivatives, MEPO-TR and MEPO-Fc, and the dipeptide mimetic of human growth factor GK-2H.

Sign in / Sign up

Export Citation Format

Share Document